# Clinical Cases: Posterior Pituitary Disorders

## Case 1: Central Diabetes Insipidus

### Patient Demographics
- **Age:** 32 years
- **Sex:** Male
- **Occupation:** Construction worker

### Chief Complaint
"I'm urinating constantly and can't stop drinking water - I'm up every hour at night."

### History of Present Illness
A 32-year-old man presents with a 3-week history of excessive thirst (polydipsia) and frequent urination (polyuria). He reports drinking approximately 8-10 liters of fluid daily and urinating every 30-60 minutes, including multiple times at night (nocturia). He prefers ice-cold water. He denies dysuria, hematuria, or recent medication changes. He reports fatigue and difficulty concentrating at work due to sleep disruption. Of note, he was involved in a motor vehicle accident 6 weeks ago with head trauma requiring hospitalization.

### Physical Examination
- **Vital Signs:** BP 118/76 mmHg, HR 88 bpm, Temp 37.0°C
- **General:** Alert, mildly fatigued, carrying large water bottle
- **HEENT:** Mucous membranes moist (due to continued drinking)
- **Cardiovascular:** Normal
- **Neurologic:** Alert and oriented, cranial nerves intact
- **Skin:** Normal turgor

### Workup
- **Laboratory Studies:**
  - Serum sodium: 147 mEq/L (high-normal/elevated)
  - Serum osmolality: 298 mOsm/kg (elevated, normal 275-295)
  - Urine osmolality: 85 mOsm/kg (inappropriately dilute, should be >600 if dehydrated)
  - Urine specific gravity: 1.002
  - Glucose: 92 mg/dL (rules out diabetes mellitus)
  - Calcium: 9.2 mg/dL (rules out hypercalcemia)
  - Potassium: 3.8 mEq/L
- **24-hour urine volume:** 9.5 liters
- **Water Deprivation Test:**
  - After water restriction: Urine osmolality remains <300 mOsm/kg
  - After desmopressin administration: Urine osmolality increases to 650 mOsm/kg (>50% increase)
- **MRI Pituitary/Hypothalamus:** Loss of posterior pituitary bright spot on T1-weighted imaging, thickened pituitary stalk

### Diagnosis
**Central diabetes insipidus** (post-traumatic, secondary to head injury)

### Treatment
1. **Desmopressin (DDAVP):**
   - Intranasal: 10-20 mcg once or twice daily
   - Oral: 0.1-0.4 mg two to three times daily
   - Subcutaneous: For acute situations
2. **Titrate dose** to control polyuria while avoiding hyponatremia
3. **Free access to water** - patients must be able to drink to thirst
4. **Monitor:** Serum sodium regularly, especially when starting therapy
5. **Medical alert identification**

### Clinical Pearl
Central diabetes insipidus results from deficiency of ADH (vasopressin) secretion from the posterior pituitary. The posterior pituitary "bright spot" on T1-weighted MRI represents stored vasopressin in neurosecretory granules; its absence suggests central DI. The water deprivation test differentiates central DI from nephrogenic DI: in central DI, the kidneys can concentrate urine when given exogenous desmopressin, while in nephrogenic DI, the kidneys are resistant to ADH and do not respond. Post-traumatic central DI may be transient (recovering in weeks to months) or permanent, depending on the extent of hypothalamic/pituitary stalk injury.

### Clinical Image
![Posterior Pituitary Bright Spot](case_01_image.jpg)

*Sagittal T1-weighted MRI comparing normal posterior pituitary bright spot (left) with absence of bright spot in central diabetes insipidus (right).*

**Image Source:** Radiopaedia - "Posterior pituitary bright spot"
**License:** CC BY-NC-SA 3.0
**URL:** https://radiopaedia.org/cases/posterior-pituitary-bright-spot

---

## Case 2: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

### Patient Demographics
- **Age:** 68 years
- **Sex:** Male
- **Occupation:** Retired postal worker

### Chief Complaint
"I've been confused and weak for the past few days."

### History of Present Illness
A 68-year-old man with a 50 pack-year smoking history is brought to the emergency department by his daughter due to progressive confusion and weakness over 4 days. He has had decreased appetite, nausea, and mild headache. He has not had vomiting, fever, or focal neurologic symptoms. His daughter notes he seems "not himself" and has been unsteady when walking. He has no history of liver, kidney, or heart disease. He has lost 15 pounds unintentionally over the past 3 months and has developed a new cough.

### Physical Examination
- **Vital Signs:** BP 138/82 mmHg, HR 76 bpm, Temp 37.1°C
- **General:** Confused, oriented to person and place but not time
- **HEENT:** Moist mucous membranes, no JVD
- **Cardiovascular:** Normal heart sounds, no peripheral edema
- **Pulmonary:** Decreased breath sounds right upper lobe
- **Neurologic:** Slow to answer questions, mild ataxia, no focal deficits
- **Volume status:** Clinically euvolemic

### Workup
- **Laboratory Studies:**
  - Serum sodium: 118 mEq/L (severely low)
  - Serum osmolality: 248 mOsm/kg (low)
  - Urine osmolality: 520 mOsm/kg (inappropriately concentrated)
  - Urine sodium: 68 mEq/L (elevated >40)
  - BUN: 8 mg/dL (low)
  - Creatinine: 0.7 mg/dL
  - Uric acid: 2.8 mg/dL (low)
  - TSH: 2.4 mIU/L (normal)
  - Morning cortisol: 14 μg/dL (normal)
- **Chest X-ray:** 3 cm right upper lobe mass
- **CT Chest:** Right upper lobe mass concerning for malignancy with mediastinal lymphadenopathy

### Diagnosis
**SIADH** secondary to suspected small cell lung carcinoma (paraneoplastic)

### Treatment
1. **Immediate management:**
   - Fluid restriction (800-1000 mL/day)
   - Hypertonic saline (3%) if severe symptoms (seizures, severe confusion)
   - Target sodium correction: 6-8 mEq/L in first 24 hours (avoid >10-12 mEq/L/day to prevent osmotic demyelination syndrome)
2. **If refractory to fluid restriction:**
   - Salt tablets with loop diuretic
   - Vasopressin receptor antagonists (tolvaptan) - use with caution
   - Demeclocycline (induces nephrogenic DI)
3. **Treat underlying cause:** Oncology referral for lung cancer evaluation and treatment
4. **Monitor:** Serum sodium every 4-6 hours during acute correction

### Clinical Pearl
SIADH is characterized by hyponatremia with inappropriately concentrated urine (urine osmolality >100 mOsm/kg when serum osmolality is low) in a euvolemic patient with no other explanation for water retention. Key diagnostic criteria include: hypotonic hyponatremia, urine osmolality >100 mOsm/kg, euvolemia, urine sodium >40 mEq/L, and normal thyroid/adrenal function. Small cell lung cancer is the most common malignant cause of SIADH due to ectopic ADH production. The rate of sodium correction is critical - overly rapid correction can cause osmotic demyelination syndrome (central pontine myelinolysis), a devastating neurological condition.

### Clinical Image
![SIADH Diagnostic Algorithm](case_02_image.jpg)

*Diagnostic algorithm for hyponatremia showing the pathway to SIADH diagnosis based on volume status and urine studies.*

**Image Source:** Wikimedia Commons - "Hyponatremia algorithm"
**License:** CC BY-SA 4.0
**URL:** https://commons.wikimedia.org/wiki/File:Hyponatremia_Causes.svg

---

## Case 3: Post-Operative Diabetes Insipidus - Triphasic Response

### Patient Demographics
- **Age:** 41 years
- **Sex:** Female
- **Occupation:** Nurse

### Chief Complaint
Post-operative monitoring after transsphenoidal surgery.

### History of Present Illness
A 41-year-old woman underwent transsphenoidal resection of a non-functioning pituitary macroadenoma 36 hours ago. Surgery was uncomplicated. She is being monitored in the neurosurgical ICU. Over the past 12 hours, nursing staff have noted dramatically increased urine output (averaging 400-500 mL/hour) with dilute-appearing urine. She reports intense thirst and has been drinking large amounts of water. Prior to this, her urine output in the first 24 hours post-operatively was normal.

### Physical Examination
- **Vital Signs:** BP 108/68 mmHg, HR 98 bpm, Temp 36.8°C
- **General:** Alert, thirsty
- **HEENT:** Nasal packing in place
- **Cardiovascular:** Tachycardia, regular rhythm
- **Neurologic:** Alert, oriented, no visual complaints

### Workup
- **Laboratory Studies:**
  - Serum sodium: 148 mEq/L (elevated)
  - Serum osmolality: 305 mOsm/kg (elevated)
  - Urine osmolality: 95 mOsm/kg (dilute)
  - Urine specific gravity: 1.001
- **Urine output:** 5.2 liters over past 12 hours

### Diagnosis
**Post-operative central diabetes insipidus** - Phase 1 of the triphasic response

### Treatment
1. **Phase 1 (DI phase - current):**
   - Desmopressin (DDAVP) 1-2 mcg IV or 10 mcg intranasally
   - Careful fluid replacement (match output with hypotonic fluids)
   - Frequent sodium monitoring (every 4-6 hours)
2. **Anticipate Phase 2 (SIADH phase):**
   - Typically occurs days 2-7 post-operatively
   - Hold desmopressin, fluid restrict if sodium drops
   - Monitor for hyponatremia
3. **Anticipate Phase 3:**
   - Permanent DI vs. recovery
   - May need long-term DDAVP or may resolve completely
4. **Strict intake/output monitoring**

### Clinical Pearl
The triphasic response after pituitary surgery reflects the dynamic changes in ADH release from damaged neurons: Phase 1 (DI) occurs when surgical trauma causes acute dysfunction of ADH-secreting neurons; Phase 2 (SIADH) occurs 2-7 days later when dying neurons release stored ADH in an uncontrolled manner; Phase 3 represents permanent DI if >90% of neurons are destroyed, or recovery if sufficient neurons survive. Not all patients experience all three phases - some have only transient DI, isolated SIADH, or permanent DI. Careful monitoring of sodium and urine output, with thoughtful use of DDAVP and fluids, is essential to avoid both severe hypernatremia and dangerous hyponatremia during this period.

### Clinical Image
![Triphasic Response Graph](case_03_image.jpg)

*Schematic representation of the triphasic response after pituitary surgery showing patterns of urine output and serum sodium over time.*

**Image Source:** Radiopaedia - "Triphasic response pituitary surgery"
**License:** CC BY-NC-SA 3.0
**URL:** https://radiopaedia.org/articles/triphasic-response-of-diabetes-insipidus